// App-Quantinova.ai

2185 : Sann-Joong-Kuey-Jian-Tang can inhibit human breast cancer cells through dural- blocking both the Ras/Raf/MEK/ERK and Ras/PI3K/Akt/mTOR pathways

Researchers

Presenter

  • CHIN CHENG SU

Principal Investigators

  • N/A

Medical Centers

  • CHANGHUA CHRISTIAN HOSPITAL, CHANGHUA, Taiwan.

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Extracellular signal-regulated kinase

  • Kinase Insert Domain Receptor

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Rapacan

  • Methadone hydrochloride

  • L-Tyrosine

  • BT-20

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved